Allison Moore, Founder and CEO of the Hereditary Neuropathy Foundation, shares her perspective on the past, present, and future of CMT research. In this talk, she covers where the field has been, the progress being made today, and what the CMT community can expect in the years ahead.

For the latest updates on research programs and clinical trials, visit our GRIN Patient Registry page and explore our research initiatives.